» Articles » PMID: 23300883

Evaluation of Ghost Cell Survival in the Area of Radiofrequency Ablation

Overview
Journal PLoS One
Date 2013 Jan 10
PMID 23300883
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Researchers have demonstrated dead cells in radiofrequency ablation (RFA) lesions that have morphological similarities to viable tumor cells and are thus referred to as ghost cells. However, studies on how long ghost cells persist have not been systematically performed.

Methods: A tumor model was established by implanting VX2 tumor tissue into the livers of 48 New Zealand rabbits. Two weeks later, these tumors were eliminated with RFA. The lesions were resected at 0 weeks, 1 week, 2 weeks, 4 weeks, 8 weeks, or 12 weeks after treatment, and samples were stained either with hematoxylin and eosin (HE) or nicotinamide adenine dinucleotide (NADH). The presence of the cells and the morphological changes that they underwent were examined by light microscopy.

Results: Four weeks after RFA, there were no obvious morphological changes observed in HE-stained ghost cells, and NADH staining revealed no viable cells. Eight weeks after RFA, the cell structure became indistinct. Twelve weeks after RFA, ghost cells were no longer present.

Conclusions: The morphological characteristics of ghost cells are maintained for at least 4 weeks, during which time HE staining cannot be used to differentiate ghost cells from residual tumor cells. NADH staining for cell viability is necessary to differentiate residual tumor cells from ghost cells. This evidence adds to our understanding of the mechanisms of RFA when used on solid tumors.

Citing Articles

Percutaneous core-needle biopsy before and immediately after coaxial microwave ablation in solid non-small cell lung cancer: the comparison of genomic testing from specimens.

Xu S, He L, Qi J, Kong F, Bie Z, Li Y Cancer Imaging. 2023; 23(1):93.

PMID: 37789413 PMC: 10548670. DOI: 10.1186/s40644-023-00610-6.


CT perfusion imaging can detect residual lung tumor early after radiofrequency ablation: a preliminary animal study on both tumoral and peri-tumoral region assessment.

Cheng Z, Wang Y, Yuan M, Liang J, Feng Y, Shi Y J Thorac Dis. 2022; 14(1):64-75.

PMID: 35242369 PMC: 8828527. DOI: 10.21037/jtd-21-967.


Synchronous microwave ablation followed by core-needle biopsy via a coaxial cannula for highly suspected malignant lung ground-glass opacities: A single-center, single-arm retrospective study.

Kong F, Bie Z, Li Y, Li B, Guo R, Wang C Thorac Cancer. 2021; 12(23):3216-3222.

PMID: 34672102 PMC: 8636204. DOI: 10.1111/1759-7714.14189.


Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming.

Wang P, Jin J, Liang X, Yu M, Yang C, Huang F Acta Pharmacol Sin. 2021; 43(6):1581-1593.

PMID: 34462561 PMC: 9160019. DOI: 10.1038/s41401-021-00750-0.


Pathologic Diagnosis and Genetic Analysis of Sequential Biopsy Following Coaxial Low-Power Microwave Thermal Coagulation For Pulmonary Ground-Glass Opacity Nodules.

Chi J, Ding M, Wang Z, Hu H, Shi Y, Cui D Cardiovasc Intervent Radiol. 2021; 44(8):1204-1213.

PMID: 33825064 DOI: 10.1007/s00270-021-02782-9.


References
1.
Swistel A, Bading J, Raaf J . Intraarterial versus intravenous adriamycin in the rabbit Vx-2 tumor system. Cancer. 1984; 53(6):1397-404. DOI: 10.1002/1097-0142(19840315)53:6<1397::aid-cncr2820530630>3.0.co;2-e. View

2.
Miao Y, Ni Y, Mulier S, Yu J, De Wever I, Penninckx F . Treatment of VX2 liver tumor in rabbits with "wet" electrode mediated radio-frequency ablation. Eur Radiol. 2000; 10(1):188-94. DOI: 10.1007/s003300050031. View

3.
Glantzounis G, Yang W, Koti R, Mikhailidis D, Seifalian A, Davidson B . Continuous infusion of N-acetylcysteine reduces liver warm ischaemia-reperfusion injury. Br J Surg. 2004; 91(10):1330-9. DOI: 10.1002/bjs.4694. View

4.
Ng K, Poon R, Lam C, Yuen J, Tso W, Fan S . Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion. Br J Surg. 2006; 93(4):440-7. DOI: 10.1002/bjs.5267. View

5.
Ypsilantis P, Pitiakoudis M, Souftas V, Lambropoulou M, Tsalikidis C, Foutzitzi S . Liver regeneration following radiofrequency ablation. J Surg Res. 2008; 150(1):60-5. DOI: 10.1016/j.jss.2007.09.019. View